Obstetrical Society of London

DotLab announces three granted patents for its non-invasive test for endometriosis, DotEndo™

Retrieved on: 
Friday, August 19, 2022

Via its clinical studies, DotLab has pioneered medical tests enabled by single-stranded, non-coding RNAs called microRNAs in circulating body fluids such as blood and saliva.

Key Points: 
  • Via its clinical studies, DotLab has pioneered medical tests enabled by single-stranded, non-coding RNAs called microRNAs in circulating body fluids such as blood and saliva.
  • The inventions embodied in the portfolio of granted patents U.S. Patent No.
  • 11,315,660 B2 also include the company's proprietary machine learning algorithms to detect, predict, diagnose, and monitor the presence or absence of the disease.
  • EMPOWER is the most robust clinical study of its type ever performed, making it an excellent foundation for thecommercial test.

Michael I. Balat is recognized by Continental Who's Who

Retrieved on: 
Monday, November 15, 2021

HOUSTON, Nov. 15, 2021 /PRNewswire/ --Michael I. Balat, MD, is being recognized by Continental Who's Who as a Distinguished OBGYN for his excellent work in the Medical field and in recognition of his work at his private practice, Michael I. Balat, MD.

Key Points: 
  • HOUSTON, Nov. 15, 2021 /PRNewswire/ --Michael I. Balat, MD, is being recognized by Continental Who's Who as a Distinguished OBGYN for his excellent work in the Medical field and in recognition of his work at his private practice, Michael I. Balat, MD.
  • Michael I. Balat, MD, currently works at Plaza OBGYN, his family's practice.
  • Dr. Balat loves to help couples become new parents through his work in infertility and high-risk obstetrics.
  • Dr. Balat would like to dedicate this honorable recognition to his father Dr. Isam, and Nahla Balat, thanking them for their love and support.